The long term objectives of this project are to determine the mechanisms by which erythropoietin (EPO) contributes to the control of the proliferation and differentiation of erythrocytes. Erythroid lineage differentiation initiates with the commitments of a pluripotential progenitor. One marker of lineage commitment is the expression of a high-affinity receptor for EPO and the acquisition of an ability to proliferate in response to EPO and to begin to express additional erythroid lineage specific markers, including the globin genes. The studies proposed in this project focus on the signalling events involved in the response of cells to EPO. In the first specific aim, studies are proposed to identify the functional domains of the EPO receptor that are required for differentiation. Conversely, experiments will be done to define the domains of the IL-3 receptor that can dominantly suppress EPO-induced expression of erythroid markers. In particular, both receptors contain membrane distal, carboxyl-domains that are required for the activation of the ras signalling pathway and a membrane proximal domain that is required for activation of the JAK/STAT pathway. Various mutated receptors will be used to determine which pathways are involved in promoting or suppressing expression of erythroid lineage specific markers. In the second specific aim, the studies focus on the role of novel STAT proteins in signalling in erythroid lineage cells. Recent studies have demonstrated that the substrates of JAK kinases include transcriptional factors of the STAT family. Recently a family member (STAT4) has been cloned that is expressed in myeloid cells and whose expression is extinguished during the continued commitment to the erythroid lineage. Studies are proposed to determine the role of STAT4 in erythroid lineage commitment. Since additional serologically and functionally related proteins exist, experiments are proposed to clone additional STAT proteins and to assess their role in signal transduction through the EPO receptor. Collectively, these studies will contribute to an understanding of the initial signal transduction events that occur through the EPO receptor and contribute to proliferation and differentiation of erythrocytes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL053749-03
Application #
5214230
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Zhao, Hui Fen; Abraham, Allistair; Kim, Yoon-Sang et al. (2017) Lentiviral Transfer of ?-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine ?-Thalassemia. Mol Ther 25:593-605
De Ravin, Suk See; Wu, Xiaolin; Moir, Susan et al. (2016) Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med 8:335ra57
Abraham, Allistair; Kim, Yoon-Sang; Zhao, Huifen et al. (2016) Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2r?null Mice by Lentiviral Expression of NUP98-HOXA10HD. PLoS One 11:e0147059
Wielgosz, Matthew M; Kim, Yoon-Sang; Carney, Gael G et al. (2015) Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev 2:14063
Pestina, Tamara I; Hargrove, Phillip W; Zhao, Huifen et al. (2015) Amelioration of murine sickle cell disease by nonablative conditioning and ?-globin gene-corrected bone marrow cells. Mol Ther Methods Clin Dev 2:15045
Zhou, Sheng; Bonner, Melissa A; Wang, Yong-Dong et al. (2015) Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems. Hum Gene Ther Methods 26:4-12
Urbinati, Fabrizia; Hargrove, Phillip W; Geiger, Sabine et al. (2015) Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. Exp Hematol 43:346-351
Treanor, Louise M; Zhou, Sheng; Janke, Laura et al. (2014) Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. J Exp Med 211:701-13
Griffith, Linda M; Cowan, Morton J; Notarangelo, Luigi D et al. (2014) Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol 133:335-47
De Ravin, Suk See; Gray, John T; Throm, Robert E et al. (2014) False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Mol Ther 22:244-245

Showing the most recent 10 out of 152 publications